SAL067

· Shenzhen Salubris Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SAL067, covering 2023-03-23 to 2023-04-06. Get the full timeline:

Most recent: Clinical Trial Update: SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled by Metformin [Phase 3]